Vektor Medical Strengthens Its Medical Advisory Board with World-renowned Leaders in Electrophysiology

SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a pioneer in arrhythmia care and developer of the only FDA-cleared non-invasive technology to accurately map arrhythmias using just 12-lead ECG data, is delighted to announce the expansion of its esteemed Medical Advisory Board.

The newly expanded Medical Advisory Board, features preeminent electrophysiology leaders, including:

• Dr. John Miller at Indiana University Health
• Dr. Jag Singh at Mass General Brigham
• Dr. Ben D’Souza at UPenn Medicine
• Dr. Ulrika Birgersdotter-Green at UC San Diego Health
• Dr. David Haines at Beaumont Hospital
• Dr. Gery Tomassoni at Baptist Health
• Dr. Greg Feld at UC San Diego Health

"I'm very enthusiastic about vMap's potential to transform cardiac arrhythmia care. Its AI-based, non-invasive approach, coupled with the remarkable clinical results, holds game-changing promise for procedural efficiency and, most importantly, patient outcomes," said Dr. John Miller, world renowned electrophysiologist and the Head of EP Fellowship Training Program at Indiana University School of Medicine. "What truly stands out is vMap's ability to leverage the simplicity and accessibility of ECG data, a universally available diagnostic tool. This not only streamlines the workflow but also extends life-saving care to a broader patient population. vMap is raising everyone’s game, making expert-level data interpretation accessible to all electrophysiologists and cardiologists, thus shifting the paradigm in the standard of cardiac arrhythmia care."

"The dilemma healthcare providers are facing right now is how to increase access to cardiovascular care, while health systems are stretched and resources are limited. Non-invasive, digital tools like vMap, powered by artificial intelligence algorithms, are not only enhancing physician’s ability to diagnose and treat cardiac arrhythmias with unprecedented accuracy and efficiency, but also spearheading healthcare transformation through digital innovation, enabling health providers deliver care to more patients,” said Dr. Jag Singh, Professor of Medicine at Harvard Medical School, the Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program at the Massachusetts General Hospital Heart Center and the former Clinical Director of the Cardiology Division and the Roman W. DeSanctis Endowed Chair in Cardiology at Mass General Hospital. “vMap stands at the forefront of this digital revolution, showcasing how artificial intelligence and data can be harnessed for the greater good. I look forward to partnering with Vektor on its mission to revolutionize arrhythmia care and increasing access to safer, more personalized and affordable patient centered care across all communities and all human beings.”

With this distinguished Medical Advisory Board, Vektor Medical is poised to further advance its impact in arrhythmia care. These experts will play a pivotal role in guiding the company’s cutting-edge product roadmap and ensuring that Vektor Medical remains at the forefront of cardiac arrhythmia care innovation. Their collective clinical expertise and experience with novel technologies addressing critical unmet needs will drive the development of new solutions aimed at improving patient outcomes, optimizing workflows, and transforming arrhythmia care.

Vektor Medical is committed to its mission to revolutionize cardiac arrhythmia care, and the addition of these prominent experts to its Medical Advisory Board represents a significant step towards realizing that vision.

About vMap®

vMap is the only FDA-cleared, non-invasive AI-based solution for mapping arrhythmias, utilizing just a 12-lead ECG. vMap leverages AI-based algorithms to locate arrhythmia sources for focal and fibrillation-type arrhythmias, including atrial fibrillation. By unlocking actionable insights contained within a standard 12-lead ECG, vMap enables physicians to rapidly and accurately locate arrhythmia source locations. Backed by clinical evidence, vMap not only improves cardiac ablation outcomes but also reduces procedure time, optimizing workflow across the entire arrhythmia care pathway.

About Vektor Medical ^®

Headquartered in San Diego, Vektor Medical is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology (vMap), the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency.

For more information about vMap and Vektor Medical, please visit www.vektormedical.com